Journal rankings · indicator year 2000
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2000
Immunology journal rankings 2000
56 ranked journals · Subfield in Immunology and Microbiology
Immunology has 56 ranked journals in 2000. The median journal has an OJR of 0.72, below the world average of 1.00; Q1 starts at OJR 1.02. The top three are Immunity, The Journal of Experimental Medicine, and Annual Review of Immunology.
Ranks and citation indicators: 2000. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1997–1999, the window the 2000 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
56 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 1999. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1997–1999, the window the 2000 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1997–1999 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2000. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 6.41Q1 | 21.01no 1999 value | 473 | 100% | $10,400 | — | |
2The Journal of Experimental MedicineRockefeller University Press · United States | 4.97Q1 | 14.95no 1999 value | 1,335 | 100% | — | — | |
3Annual Review of ImmunologyAnnual Reviews · United States | 4.18Q1 | 52.53no 1999 value | 84 | 6% | — | — | |
4Immunology TodayElsevier BV · United Kingdom | 3.19Q1 | 8.63no 1999 value | 519 | 4% | — | — | |
5Critical Reviews in ImmunologyBegell House · United States | 2.93Q1 | 6.72no 1999 value | 67 | 3% | — | — | |
6The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.13Q1 | 6.74no 1999 value | 4,985 | 48% | $3,500 | — | |
7Seminars in ImmunologyElsevier BV · United States | 2.06Q1 | 6.18no 1999 value | 131 | 7% | $4,370 | — | |
8Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 1.69Q1 | 4.44no 1999 value | 1,218 | 43% | $4,900 | — | |
9Journal of Leukocyte BiologyOxford University Press · United States | 1.51Q1 | 4.34no 1999 value | 696 | 10% | $3,800 | — | |
10European Journal of ImmunologyWiley · Germany | 1.51Q1 | 4.02no 1999 value | 1,696 | 49% | $4,550 | — | |
11International Reviews of ImmunologyTaylor & Francis · United States | 1.45Q1 | 4.59no 1999 value | 111 | 3% | — | — | |
12International ImmunologyOxford University Press · United Kingdom | 1.04Q1 | 3.15no 1999 value | 622 | 36% | $3,530 | — | |
13Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.03Q1 | 2.58no 1999 value | 1,004 | 96% | $3,816 | — | |
14Current Opinion in ImmunologyElsevier BV · United Kingdom | 1.02Q1 | 9.11no 1999 value | 415 | 10% | $4,410 | — | |
15Clinical ImmunologyElsevier BV · Netherlands | 1.01Q2 | 2.17no 1999 value | 171 | 9% | $4,400 | — | |
16Journal of Clinical ImmunologySpringer Science+Business Media · United States | 0.99Q2 | 2.85no 1999 value | 189 | 0% | $4,990 | — | |
17Immunologic ResearchSpringer Science+Business Media · United States | 0.97Q2 | 2.34no 1999 value | 117 | 7% | $2,890 | — | |
18Springer Seminars in ImmunopathologySpringer Science+Business Media · Germany | 0.93Q2 | 2.18no 1999 value | 126 | 2% | — | — | |
19Journal of Immunological MethodsElsevier BV · Netherlands | 0.93Q2 | 2.00no 1999 value | 635 | 3% | $2,970 | — | |
20Toxicologic PathologySAGE Publishing · United States | 0.91Q2 | 2.21no 1999 value | 319 | 30% | $4,150 | — | |
21Journal of AutoimmunityElsevier BV · United Kingdom | 0.91Q2 | 2.14no 1999 value | 207 | 4% | $5,420 | — | |
22ImmunologyWiley · United Kingdom | 0.89Q2 | 2.25no 1999 value | 789 | 92% | $5,330 | — | |
23CytokineElsevier BV · United Kingdom | 0.82Q2 | 2.41no 1999 value | 253 | 4% | $3,220 | — | |
24Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.81Q2 | 2.07no 1999 value | 398 | 2% | — | — | |
25Immunology and Cell BiologyWiley · Australia | 0.77Q2 | 2.19no 1999 value | 242 | 7% | $3,750 | — | |
26ImmunogeneticsSpringer Science+Business Media · Germany | 0.76Q2 | 2.10no 1999 value | 440 | 1% | $2,890 | — | |
27American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.75Q2 | 1.77no 1999 value | 369 | 6% | $4,460 | — | |
28Cellular ImmunologyElsevier BV · Netherlands | 0.72Q2 | 1.86no 1999 value | 517 | 5% | $3,550 | — | |
29Human ImmunologyElsevier BV · United States | 0.72Q3 | 1.85no 1999 value | 395 | 4% | $3,600 | — | |
30Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 0.70Q3 | 6.19no 1999 value | 63 | 15% | $4,900 | — | |
31ImmunobiologyOAElsevier BV · Germany | 0.67Q3 | 1.69no 1999 value | 213 | 2% | $2,840 | — | |
32Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.66Q3 | 1.84no 1999 value | 481 | 50% | $4,480 | — | |
33Immunological ReviewsWiley · United States | 0.65Q3 | 6.48no 1999 value | 359 | 6% | $5,000 | — | |
33Journal of Reproductive ImmunologyElsevier BV · Netherlands | 0.65Q3 | 2.03no 1999 value | 195 | 0% | $3,690 | — | |
35ImmunopharmacologyElsevier BV · Netherlands | 0.64Q3 | 1.39no 1999 value | 321 | 1% | — | — | |
36International Journal of Clinical & Laboratory ResearchSpringer Science+Business Media · Germany | 0.64Q3 | 1.54no 1999 value | 120 | 3% | — | — | |
37Tissue AntigensWiley · United Kingdom | 0.63Q3 | 2.42no 1999 value | 584 | 12% | — | — | |
38Immunology LettersElsevier BV · Netherlands | 0.59Q3 | 1.59no 1999 value | 490 | 4% | $3,290 | — | |
39Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 0.58Q3 | 1.14no 1999 value | 87 | 0% | $5,490 | — | |
40Inflammation ResearchSpringer Science+Business Media · Switzerland | 0.56Q3 | 1.55no 1999 value | 472 | 1% | $4,790 | — | |
41Bulletin of the European Association of Fish PathologistsPublisher not listed | 0.55Q3 | 1.11no 1999 value | 47 | 0% | — | — | |
42Experimental and Clinical ImmunogeneticsKarger Publishers · Switzerland | 0.53Q3 | 2.13no 1999 value | 62 | 8% | — | — | |
43Veterinary Immunology and ImmunopathologyElsevier BV · Netherlands | 0.52Q4 | 1.45no 1999 value | 521 | 8% | $3,250 | — | |
44European Journal of ImmunogeneticsWiley · United Kingdom | 0.46Q4 | 1.30no 1999 value | 144 | 2% | — | — | |
45International Journal of ImmunopharmacologyElsevier BV · United Kingdom | 0.45Q4 | 1.20no 1999 value | 229 | 3% | — | — | |
46Journal of Aquatic Animal HealthWiley · United States | 0.38Q4 | 0.97no 1999 value | 141 | 7% | $3,500 | — | |
47Immunological InvestigationsTaylor & Francis · United States | 0.38Q4 | 0.64no 1999 value | 118 | 0% | — | — | |
48Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 0.37Q4 | 1.53no 1999 value | 164 | 10% | $4,330 | — | |
49Molecular ImmunologyElsevier BV · Netherlands | 0.33Q4 | 0.83no 1999 value | 671 | 2% | $3,340 | — | |
50Journal of Fish DiseasesWiley · United Kingdom | 0.30Q4 | 0.81no 1999 value | 185 | 5% | $5,450 | — |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2000. Corpus-wide, 66.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
18 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1997–1999, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2000. Publication window: 1997–1999. How these summaries are calculated
- Ranked journals
- 56
- Window papers (baseline)
- 33,673 Change unavailable from indicator year 1997
- Median OJR
- 0.72 Change unavailable from indicator year 1997
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1997–1999 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.